Dr. Andy Itsara, M.D.
Claim this profileStudies Lymphoma
Studies Cancer
1 reported clinical trial
1 drug studied
Area of expertise
1Lymphoma
17p deletion positive
p53 positive
2Cancer
17p deletion positive
p53 positive
More about Andy Itsara, M.D.
Clinical Trial Related13 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Andy Itsara, M.D. has experience with
- PCI-32765
Breakdown of trials Andy Itsara, M.D. has run
T-Lymphoblastic Leukemia/Lymphoma
Lymphoid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andy Itsara, M.D. specialize in?
Andy Itsara, M.D. focuses on Lymphoma and Cancer. In particular, much of their work with Lymphoma has involved 17p deletion positive patients, or patients who are p53 positive.
Is Andy Itsara, M.D. currently recruiting for clinical trials?
No, Andy Itsara, M.D. is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Andy Itsara, M.D. has studied deeply?
Yes, Andy Itsara, M.D. has studied treatments such as PCI-32765.
What is the best way to schedule an appointment with Andy Itsara, M.D.?
Apply for one of the trials that Andy Itsara, M.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.